RL
Ronald Allen Louks
Chief Operating Officer

Ronald Allen Louks insider trades: NantHealth (NH) stock sales

Chief Operating Officer, NantHealth Last trade Sep 13, 2021 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
16
Open-market trades
since 2017
1
Company
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Ronald reports to the SEC

Open-market buys and sales

16 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 13, 2021NH↓ Sell$33K
Sep 8, 2021NH↓ Sell$52K
Mar 12, 2021NH↓ Sell$297K
Oct 6, 2018NH↓ Sell$9K
Sep 6, 2018NH↓ Sell$12K
Aug 6, 2018NH↓ Sell$20K
Jul 6, 2018NH↓ Sell$20K
Jun 6, 2018NH↓ Sell$20K
May 6, 2018NH↓ Sell$24K
Apr 6, 2018NH↓ Sell$21K
Mar 6, 2018NH↓ Sell$25K
Feb 6, 2018NH↓ Sell$20K
Jan 8, 2018NH↓ Sell$22K
Dec 6, 2017NH↓ Sell$16K
Nov 6, 2017NH↓ Sell$23K
Oct 6, 2017NH↓ Sell$115K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Ronald Allen Louks's insider trades

Ronald Allen Louks is Chief Operating Officer at NantHealth (NH). Since Oct 6, 2017, Ronald has reported no open-market purchases and 16 sales worth $728K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (18 filings), shares withheld for taxes (16 filings), grants and awards (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.